5thPort Simplifies Adoption of eConsent Technology with FDA 21 CFR Part 11 Compliance
5thPort Simplifies Adoption of eConsent Technology with FDA 21 [...]
Long Live Decentralized Trials
Long Live Decentralized TrialsSummaryDecentralized clinical trials use digital tools, remote [...]
5thPort Simplifies Adoption of eConsent Technology with FDA 21 CFR Part 11 Compliance
In our continued commitment to helping our clients satisfy their audit requirements, we're pleased to announce that the 5thPort eConsent and patient engagement platform has been certified as compliant with FDA 21 CFR Part 11 & EU's EUDRALEX ANNEX 11.
8 Common Misconceptions About Clinical Trials
8 Common Clinical Trial MisconceptionsSummaryClinical trials are often misunderstood. Common [...]
7 Steps to Improve Participant Retention in Clinical Trials
7 Steps to Improve Participant Retention in Clinical TrialsSummary of [...]
Remote eConsent in the COVID-19 Era
Remote eConsent in the COVID-19 Era Summary of Article [...]